SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-082117
Filing Date
2022-12-22
Accepted
2022-12-22 14:21:40
Documents
14
Period of Report
2022-12-21
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea170747-8k425_viveon.htm   iXBRL 8-K 56221
2 PRESS RELEASE DATED DECEMBER 21, 2022 ea170747ex99-1_viveon.htm EX-99.1 14743
  Complete submission text file 0001213900-22-082117.txt   312637

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vhaq-20221221.xsd EX-101.SCH 3851
4 XBRL DEFINITION FILE vhaq-20221221_def.xml EX-101.DEF 27199
5 XBRL LABEL FILE vhaq-20221221_lab.xml EX-101.LAB 37383
6 XBRL PRESENTATION FILE vhaq-20221221_pre.xml EX-101.PRE 25815
8 EXTRACTED XBRL INSTANCE DOCUMENT ea170747-8k425_viveon_htm.xml XML 7071
Mailing Address C/O GIBSON, DEAL, AND FLETCHER, P. C. 3953 NORCROSS GA 30092
Business Address C/O GIBSON, DEAL, AND FLETCHER, P. C. 3953 NORCROSS GA 30092 4045797978
Viveon Health Acquisition Corp. (Filer) CIK: 0001823857 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39827 | Film No.: 221481541
SIC: 2834 Pharmaceutical Preparations